Cite
HARVARD Citation
Voskaridou, E. et al. (2019). Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis. Hematology. 24 (1), pp. 318-324. [Online].